Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Overall safety is increasing, but new safety hazards, such as repetitive stress injuries and potential toxicities from nanoparticles, are coming under closer scrutiny.
Researchers try multiple means to get high-quality membrane proteins for X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy studies.
Rapid progress with induced pluripotent stem cells is bringing scientists closer to understanding their strengths and weaknesses as embryonic stem cell stand-ins.
They are the quintessential drug target—but the dynamic structures and highly elaborate mechanisms of G protein–coupled receptors continue to keep experts in both industry and academia on their toes.
Antibodies, the molecular workhorses of protein research, have traditionally been one of the most difficult reagents to procure. Using innovative new technologies, though, a burgeoning antibody production industry is turning these molecules into commodities.
Neuroscientists are taking advantage of powerful new tools for fluorescence imaging that enable detailed visualization of the structure and activity of neuronal circuits within the living brain.
Although many intricate microfluidic devices have been created in academic laboratories around the world, far fewer have been commercialized for wider use. But several efforts are underway to bridge this divide.
With the realization that cells interact extensively with their surrounding microenvironments during growth and development, the challenge for researchers has become designing three-dimensional culture systems that more closely mimic those relationships.